Stabilized collagen scaffolds for heart valve tissue engineering.

Scaffolds for heart valve tissue engineering must function immediately after implantation but also need to tolerate cell infiltration and gradual remodeling. We hypothesized that moderately cross-linked collagen scaffolds would fulfill these requirements. To test our hypothesis, scaffolds prepared from decellularized porcine pericardium were treated with penta-galloyl glucose (PGG), a collagen-binding polyphenol, and tested for biodegradation, biaxial mechanical properties, and in vivo biocompatibility. For controls, we used un-cross-linked scaffolds and glutaraldehyde-treated scaffolds. Results confirmed complete pericardium decellularization and the ability of scaffolds to encourage fibroblast chemotaxis and to aid in creation of anatomically correct valve-shaped constructs. Glutaraldehyde cross-linking fully stabilized collagen but did not allow for tissue remodeling and calcified when implanted subdermally in rats. PGG-treated collagen was initially resistant to collagenase and then degraded gradually, indicating partial stabilization. Moreover, PGG-treated pericardium exhibited excellent biaxial mechanical properties, did not calcify in vivo, and supported infiltration by host fibroblasts and subsequent matrix remodeling. In conclusion, PGG-treated acellular pericardium is a promising scaffold for heart valve tissue engineering.

[1]  G. Gerosa,et al.  Heart valve tissue engineering: research should proceed along validated routes. , 2008, The Journal of thoracic and cardiovascular surgery.

[2]  D. Simionescu,et al.  The biosynthesis of proteoglycans and interstitial collagens by bovine pericardial fibroblasts. , 1991, Experimental cell research.

[3]  Dan T Simionescu,et al.  Prevention of calcification in bioprosthetic heart valves: challenges and perspectives , 2004, Expert opinion on biological therapy.

[4]  Lin Yang,et al.  Molecular orientation of collagen in intact planar connective tissues under biaxial stretch. , 2005, Acta biomaterialia.

[5]  A. Yoganathan,et al.  Biaixal Stress–Stretch Behavior of the Mitral Valve Anterior Leaflet at Physiologic Strain Rates , 2006, Annals of Biomedical Engineering.

[6]  D. Simionescu,et al.  Structural requirements for stabilization of vascular elastin by polyphenolic tannins. , 2006, Biomaterials.

[7]  N. J. Baxter,et al.  Tannin interactions with a full‐length human salivary proline‐rich protein display a stronger affinity than with single proline‐rich repeats , 1996, FEBS letters.

[8]  D. Simionescu,et al.  Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[9]  D. Simionescu,et al.  Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. , 2003, The Journal of heart valve disease.

[10]  J. Lee,et al.  Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds , 2005 .

[11]  M. Sacks,et al.  Effects of fixation pressure on the biaxial mechanical behavior of porcine bioprosthetic heart valves with long-term cyclic loading. , 2002, Biomaterials.

[12]  D. Simionescu,et al.  Lysine-enhanced glutaraldehyde crosslinking of collagenous biomaterials. , 1991, Journal of biomedical materials research.

[13]  M. Yacoub.  Establishing Pediatric Cardiovascular Services in the Developing World: A Wake-Up Call , 2007, Circulation.

[14]  M. Williamson,et al.  Polyphenols, astringency and proline-rich proteins. , 1994, Phytochemistry.

[15]  Victor H Barocas,et al.  Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. , 2008, Tissue engineering. Part A.

[16]  Scott J Hollister,et al.  Tissue-engineered heart valve prostheses: 'state of the heart'. , 2008, Regenerative medicine.

[17]  F J Schoen,et al.  Onset and progression of experimental bioprosthetic heart valve calcification. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[18]  D. Simionescu,et al.  Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. , 2007, Biomaterials.

[19]  Michael S Sacks,et al.  Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. , 2006, Biomaterials.

[20]  Frederick J Schoen,et al.  New frontiers in the pathology and therapy of heart valve disease: 2006 Society for Cardiovascular Pathology, Distinguished Achievement Award Lecture, United States-Canadian Academy of Pathology, Atlanta, GA, February 12, 2006. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[21]  C. Eisenberg,et al.  Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. , 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[22]  Michael S Sacks,et al.  Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. , 2008, Biomaterials.

[23]  J. Fisher,et al.  Biocompatibility of acellular human pericardium. , 2007, The Journal of surgical research.

[24]  M. Oz,et al.  Transluminal aortic valve placement. A feasibility study with a newly designed collapsible aortic valve. , 1996, ASAIO journal.

[25]  M. Sacks,et al.  Time-dependent biaxial mechanical behavior of the aortic heart valve leaflet. , 2007, Journal of biomechanics.

[26]  M. Sacks,et al.  Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp--Part I: Experimental results. , 2000, Journal of biomechanical engineering.

[27]  D. Simionescu,et al.  Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. , 1996, ASAIO journal.

[28]  B. Meuris,et al.  Porcine stentless bioprostheses: prevention of aortic wall calcification by dye-mediated photo-oxidation. , 2003, Artificial organs.

[29]  J. Fisher,et al.  Biomechanical characterization of decellularized and cross-linked bovine pericardium. , 2007, The Journal of heart valve disease.

[30]  R. A. Hancock,et al.  Structure-activity relationships in the hydrophobic interactions of polyphenols with cellulose and collagen. , 2003, Biopolymers.

[31]  Peter Zilla,et al.  Prosthetic heart valves: catering for the few. , 2008, Biomaterials.

[32]  D. Simionescu,et al.  New evolution in mitral physiology and surgery: mitral stentless pericardial valve. , 1995, The Annals of thoracic surgery.

[33]  D. Simionescu,et al.  Elastin Stabilization for Treatment of Abdominal Aortic Aneurysms , 2007, Circulation.

[34]  Dan T Simionescu,et al.  Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. , 2003, Journal of biomedical materials research. Part A.

[35]  KAREN MENDELSON,et al.  Heart Valve Tissue Engineering: Concepts, Approaches, Progress, and Challenges , 2006, Annals of Biomedical Engineering.

[36]  D. Simionescu,et al.  Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves. , 1993, Journal of biomedical materials research.

[37]  R. Iozzo,et al.  Bovine pericardial proteoglycan: biochemical, immunochemical and ultrastructural studies. , 1989, Matrix.

[38]  Victor H. Barocas,et al.  Functional Tissue-Engineered Valves from Cell-Remodeled Fibrin with Commissural Alignment of Cell-Produced Collagen , 2008 .

[39]  N. Vyavahare,et al.  Role of elastin in pathologic calcification of xenograft heart valves. , 2003, Journal of biomedical materials research. Part A.

[40]  D. Simionescu,et al.  Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. , 2005, Biomaterials.

[41]  Dan T Simionescu,et al.  Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. , 2003, The Journal of heart valve disease.

[42]  J. Fisher,et al.  The use of acellular matrices for the tissue engineering of cardiac valves , 2008, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[43]  Chad S. Mcalexander,et al.  A comparison of suture retention strengths for three biomaterials. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[44]  E. Haslam.  Plant Polyphenols: Vegetable Tannins Revisited , 1989 .

[45]  V. Mironov,et al.  Tannic acid mimicking dendrimers as small intestine submucosa stabilizing nanomordants. , 2006, Biomaterials.